Baldwin Wealth Partners LLC MA Sells 140 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Baldwin Wealth Partners LLC MA lowered its position in iShares Biotechnology ETF (NASDAQ:IBB) by 7.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,790 shares of the financial services provider’s stock after selling 140 shares during the quarter. Baldwin Wealth Partners LLC MA’s holdings in iShares Biotechnology ETF were worth $237,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in IBB. SPC Financial Inc. boosted its position in iShares Biotechnology ETF by 2.4% in the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after buying an additional 75 shares during the period. Werba Rubin Papier Wealth Management boosted its holdings in shares of iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after purchasing an additional 76 shares during the period. Capital Investment Advisors LLC grew its stake in iShares Biotechnology ETF by 1.0% in the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock worth $1,381,000 after purchasing an additional 99 shares in the last quarter. Magnus Financial Group LLC increased its holdings in iShares Biotechnology ETF by 0.8% during the 4th quarter. Magnus Financial Group LLC now owns 12,967 shares of the financial services provider’s stock worth $1,714,000 after purchasing an additional 104 shares during the period. Finally, Daiwa Securities Group Inc. raised its position in iShares Biotechnology ETF by 12.0% during the 3rd quarter. Daiwa Securities Group Inc. now owns 1,028 shares of the financial services provider’s stock valued at $150,000 after purchasing an additional 110 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.8 %

Shares of IBB stock opened at $138.37 on Tuesday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The stock has a fifty day simple moving average of $136.15 and a two-hundred day simple moving average of $141.77.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.